The global Medical Strong Viscose Fiber market is projected to grow from US$ 5047 million in 2024 to US$ 5905 million by 2031, at a CAGR of 2.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Medical Strong Viscose Fiber Market

From a downstream perspective, Medical Dressings accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Medical Strong Viscose Fiber leading manufacturers including Aditya Birla Group, Lenzing, Sanyou, Sateri Chemical Fibre, Xinjiang Zhongtai, Aoyang Technology, Sateri, Shandong Bohi, Yibin Grace Group Company, Celliant, etc., dominate supply; the top five capture approximately % of global revenue, with Aditya Birla Group leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Medical Strong Viscose Fiber market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Medical Strong Viscose Fiber Market Report

Report Metric	Details
Report Name	Medical Strong Viscose Fiber Market
Accounted market size in 2024	US$ 5047 in million
Forecasted market size in 2031	US$ 5905 million
CAGR	2.3%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Viscose Filament Yarn Viscose Staple Fiber
Segment by Application	Medical Dressings Medical Bandages Other
Production by Region	North America Europe China Japan
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Aditya Birla Group, Lenzing, Sanyou, Sateri Chemical Fibre, Xinjiang Zhongtai, Aoyang Technology, Sateri, Shandong Bohi, Yibin Grace Group Company, Celliant
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Medical Strong Viscose Fiber study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Medical Strong Viscose Fiber Market growing?

Ans: The Medical Strong Viscose Fiber Market witnessing a CAGR of 2.3% during the forecast period 2025-2031.

What is the Medical Strong Viscose Fiber Market size in 2031?

Ans: The Medical Strong Viscose Fiber Market size in 2031 will be US$ 5905 million.

Who are the main players in the Medical Strong Viscose Fiber Market report?

Ans: The main players in the Medical Strong Viscose Fiber Market are Aditya Birla Group, Lenzing, Sanyou, Sateri Chemical Fibre, Xinjiang Zhongtai, Aoyang Technology, Sateri, Shandong Bohi, Yibin Grace Group Company, Celliant

What are the Application segmentation covered in the Medical Strong Viscose Fiber Market report?

Ans: The Applications covered in the Medical Strong Viscose Fiber Market report are Medical Dressings, Medical Bandages, Other

What are the Type segmentation covered in the Medical Strong Viscose Fiber Market report?

Ans: The Types covered in the Medical Strong Viscose Fiber Market report are Viscose Filament Yarn, Viscose Staple Fiber

1 Study Coverage

1.1 Introduction to Medical Strong Viscose Fiber: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Medical Strong Viscose Fiber Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Viscose Filament Yarn

1.2.3 Viscose Staple Fiber

1.3 Market Segmentation by Application

1.3.1 Global Medical Strong Viscose Fiber Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Medical Dressings

1.3.3 Medical Bandages

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Medical Strong Viscose Fiber Revenue Estimates and Forecasts 2020-2031

2.2 Global Medical Strong Viscose Fiber Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Medical Strong Viscose Fiber Sales Estimates and Forecasts 2020-2031

2.4 Global Medical Strong Viscose Fiber Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Medical Strong Viscose Fiber Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Medical Strong Viscose Fiber Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Medical Strong Viscose Fiber Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Viscose Filament Yarn Market Size by Manufacturers

4.5.2 Viscose Staple Fiber Market Size by Manufacturers

4.6 Global Medical Strong Viscose Fiber Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Medical Strong Viscose Fiber Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Medical Strong Viscose Fiber Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Medical Strong Viscose Fiber Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Medical Strong Viscose Fiber Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Medical Strong Viscose Fiber Sales and Revenue by Type (2020-2031)

7.4 North America Medical Strong Viscose Fiber Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Medical Strong Viscose Fiber Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Medical Strong Viscose Fiber Sales and Revenue by Type (2020-2031)

8.4 Europe Medical Strong Viscose Fiber Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Medical Strong Viscose Fiber Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Medical Strong Viscose Fiber Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Medical Strong Viscose Fiber Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Medical Strong Viscose Fiber Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Medical Strong Viscose Fiber Sales and Revenue by Type (2020-2031)

10.4 Central and South America Medical Strong Viscose Fiber Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Medical Strong Viscose Fiber Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Medical Strong Viscose Fiber Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Medical Strong Viscose Fiber Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Medical Strong Viscose Fiber Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Aditya Birla Group

12.1.1 Aditya Birla Group Corporation Information

12.1.2 Aditya Birla Group Business Overview

12.1.3 Aditya Birla Group Medical Strong Viscose Fiber Product Models, Descriptions and Specifications

12.1.4 Aditya Birla Group Medical Strong Viscose Fiber Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Aditya Birla Group Medical Strong Viscose Fiber Sales by Product in 2024

12.1.6 Aditya Birla Group Medical Strong Viscose Fiber Sales by Application in 2024

12.1.7 Aditya Birla Group Medical Strong Viscose Fiber Sales by Geographic Area in 2024

12.1.8 Aditya Birla Group Medical Strong Viscose Fiber SWOT Analysis

12.1.9 Aditya Birla Group Recent Developments

12.2 Lenzing

12.2.1 Lenzing Corporation Information

12.2.2 Lenzing Business Overview

12.2.3 Lenzing Medical Strong Viscose Fiber Product Models, Descriptions and Specifications

12.2.4 Lenzing Medical Strong Viscose Fiber Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Lenzing Medical Strong Viscose Fiber Sales by Product in 2024

12.2.6 Lenzing Medical Strong Viscose Fiber Sales by Application in 2024

12.2.7 Lenzing Medical Strong Viscose Fiber Sales by Geographic Area in 2024

12.2.8 Lenzing Medical Strong Viscose Fiber SWOT Analysis

12.2.9 Lenzing Recent Developments

12.3 Sanyou

12.3.1 Sanyou Corporation Information

12.3.2 Sanyou Business Overview

12.3.3 Sanyou Medical Strong Viscose Fiber Product Models, Descriptions and Specifications

12.3.4 Sanyou Medical Strong Viscose Fiber Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Sanyou Medical Strong Viscose Fiber Sales by Product in 2024

12.3.6 Sanyou Medical Strong Viscose Fiber Sales by Application in 2024

12.3.7 Sanyou Medical Strong Viscose Fiber Sales by Geographic Area in 2024

12.3.8 Sanyou Medical Strong Viscose Fiber SWOT Analysis

12.3.9 Sanyou Recent Developments

12.4 Sateri Chemical Fibre

12.4.1 Sateri Chemical Fibre Corporation Information

12.4.2 Sateri Chemical Fibre Business Overview

12.4.3 Sateri Chemical Fibre Medical Strong Viscose Fiber Product Models, Descriptions and Specifications

12.4.4 Sateri Chemical Fibre Medical Strong Viscose Fiber Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Sateri Chemical Fibre Medical Strong Viscose Fiber Sales by Product in 2024

12.4.6 Sateri Chemical Fibre Medical Strong Viscose Fiber Sales by Application in 2024

12.4.7 Sateri Chemical Fibre Medical Strong Viscose Fiber Sales by Geographic Area in 2024

12.4.8 Sateri Chemical Fibre Medical Strong Viscose Fiber SWOT Analysis

12.4.9 Sateri Chemical Fibre Recent Developments

12.5 Xinjiang Zhongtai

12.5.1 Xinjiang Zhongtai Corporation Information

12.5.2 Xinjiang Zhongtai Business Overview

12.5.3 Xinjiang Zhongtai Medical Strong Viscose Fiber Product Models, Descriptions and Specifications

12.5.4 Xinjiang Zhongtai Medical Strong Viscose Fiber Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Xinjiang Zhongtai Medical Strong Viscose Fiber Sales by Product in 2024

12.5.6 Xinjiang Zhongtai Medical Strong Viscose Fiber Sales by Application in 2024

12.5.7 Xinjiang Zhongtai Medical Strong Viscose Fiber Sales by Geographic Area in 2024

12.5.8 Xinjiang Zhongtai Medical Strong Viscose Fiber SWOT Analysis

12.5.9 Xinjiang Zhongtai Recent Developments

12.6 Aoyang Technology

12.6.1 Aoyang Technology Corporation Information

12.6.2 Aoyang Technology Business Overview

12.6.3 Aoyang Technology Medical Strong Viscose Fiber Product Models, Descriptions and Specifications

12.6.4 Aoyang Technology Medical Strong Viscose Fiber Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Aoyang Technology Recent Developments

12.7 Sateri

12.7.1 Sateri Corporation Information

12.7.2 Sateri Business Overview

12.7.3 Sateri Medical Strong Viscose Fiber Product Models, Descriptions and Specifications

12.7.4 Sateri Medical Strong Viscose Fiber Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Sateri Recent Developments

12.8 Shandong Bohi

12.8.1 Shandong Bohi Corporation Information

12.8.2 Shandong Bohi Business Overview

12.8.3 Shandong Bohi Medical Strong Viscose Fiber Product Models, Descriptions and Specifications

12.8.4 Shandong Bohi Medical Strong Viscose Fiber Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 Shandong Bohi Recent Developments

12.9 Yibin Grace Group Company

12.9.1 Yibin Grace Group Company Corporation Information

12.9.2 Yibin Grace Group Company Business Overview

12.9.3 Yibin Grace Group Company Medical Strong Viscose Fiber Product Models, Descriptions and Specifications

12.9.4 Yibin Grace Group Company Medical Strong Viscose Fiber Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Yibin Grace Group Company Recent Developments

12.10 Celliant

12.10.1 Celliant Corporation Information

12.10.2 Celliant Business Overview

12.10.3 Celliant Medical Strong Viscose Fiber Product Models, Descriptions and Specifications

12.10.4 Celliant Medical Strong Viscose Fiber Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 Celliant Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Medical Strong Viscose Fiber Industry Chain

13.2 Medical Strong Viscose Fiber Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Medical Strong Viscose Fiber Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Medical Strong Viscose Fiber Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Medical Strong Viscose Fiber Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Medical Strong Viscose Fiber Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

FEATURED COMPANIES

Lenzing

Sanyou

Sateri Chemical Fibre

Yibin Grace Group Company

Celliant

List of Tables

Table 1. Global Medical Strong Viscose Fiber Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Medical Strong Viscose Fiber Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Medical Strong Viscose Fiber Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Medical Strong Viscose Fiber Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Medical Strong Viscose Fiber Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Medical Strong Viscose Fiber Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 7. Global Medical Strong Viscose Fiber Sales by Region (2020-2025) & (Tons)

Table 8. Global Medical Strong Viscose Fiber Sales by Region (2026-2031) & (Tons)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Medical Strong Viscose Fiber Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 11. Global Medical Strong Viscose Fiber Production by Region (2020-2025) & (Tons)

Table 12. Global Medical Strong Viscose Fiber Production by Region (2026-2031) & (Tons)

Table 13. Global Medical Strong Viscose Fiber Sales by Manufacturers (2020-2025) & (Tons)

Table 14. Global Medical Strong Viscose Fiber Sales Share by Manufacturers (2020-2025)

Table 15. Global Medical Strong Viscose Fiber Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Medical Strong Viscose Fiber Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Medical Strong Viscose Fiber by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Strong Viscose Fiber as of 2024)

Table 19. Global Medical Strong Viscose Fiber Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Medical Strong Viscose Fiber Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)

Table 21. Key Manufacturers Medical Strong Viscose Fiber Manufacturing Base and Headquarters

Table 22. Global Medical Strong Viscose Fiber Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Medical Strong Viscose Fiber Sales by Type (2020-2025) & (Tons)

Table 26. Global Medical Strong Viscose Fiber Sales by Type (2026-2031) & (Tons)

Table 27. Global Medical Strong Viscose Fiber Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Medical Strong Viscose Fiber Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Medical Strong Viscose Fiber ASP by Type (2020-2031) & (US$/Ton)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Medical Strong Viscose Fiber Sales by Application (2020-2025) & (Tons)

Table 32. Global Medical Strong Viscose Fiber Sales by Application (2026-2031) & (Tons)

Table 33. Medical Strong Viscose Fiber High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Medical Strong Viscose Fiber Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Medical Strong Viscose Fiber Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Medical Strong Viscose Fiber ASP by Application (2020-2031) & (US$/Ton)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Medical Strong Viscose Fiber Growth Accelerators and Market Barriers

Table 40. North America Medical Strong Viscose Fiber Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Medical Strong Viscose Fiber Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Medical Strong Viscose Fiber Growth Accelerators and Market Barriers

Table 43. Europe Medical Strong Viscose Fiber Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Medical Strong Viscose Fiber Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Medical Strong Viscose Fiber Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Medical Strong Viscose Fiber Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Medical Strong Viscose Fiber Growth Accelerators and Market Barriers

Table 48. Southeast Asia Medical Strong Viscose Fiber Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Medical Strong Viscose Fiber Investment Opportunities and Key Challenges

Table 50. Central and South America Medical Strong Viscose Fiber Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Medical Strong Viscose Fiber Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Medical Strong Viscose Fiber Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Aditya Birla Group Corporation Information

Table 54. Aditya Birla Group Description and Major Businesses

Table 55. Aditya Birla Group Product Models, Descriptions and Specifications

Table 56. Aditya Birla Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 57. Aditya Birla Group Sales Value Proportion by Product in 2024

Table 58. Aditya Birla Group Sales Value Proportion by Application in 2024

Table 59. Aditya Birla Group Sales Value Proportion by Geographic Area in 2024

Table 60. Aditya Birla Group Medical Strong Viscose Fiber SWOT Analysis

Table 61. Aditya Birla Group Recent Developments

Table 62. Lenzing Corporation Information

Table 63. Lenzing Description and Major Businesses

Table 64. Lenzing Product Models, Descriptions and Specifications

Table 65. Lenzing Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 66. Lenzing Sales Value Proportion by Product in 2024

Table 67. Lenzing Sales Value Proportion by Application in 2024

Table 68. Lenzing Sales Value Proportion by Geographic Area in 2024

Table 69. Lenzing Medical Strong Viscose Fiber SWOT Analysis

Table 70. Lenzing Recent Developments

Table 71. Sanyou Corporation Information

Table 72. Sanyou Description and Major Businesses

Table 73. Sanyou Product Models, Descriptions and Specifications

Table 74. Sanyou Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. Sanyou Sales Value Proportion by Product in 2024

Table 76. Sanyou Sales Value Proportion by Application in 2024

Table 77. Sanyou Sales Value Proportion by Geographic Area in 2024

Table 78. Sanyou Medical Strong Viscose Fiber SWOT Analysis

Table 79. Sanyou Recent Developments

Table 80. Sateri Chemical Fibre Corporation Information

Table 81. Sateri Chemical Fibre Description and Major Businesses

Table 82. Sateri Chemical Fibre Product Models, Descriptions and Specifications

Table 83. Sateri Chemical Fibre Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 84. Sateri Chemical Fibre Sales Value Proportion by Product in 2024

Table 85. Sateri Chemical Fibre Sales Value Proportion by Application in 2024

Table 86. Sateri Chemical Fibre Sales Value Proportion by Geographic Area in 2024

Table 87. Sateri Chemical Fibre Medical Strong Viscose Fiber SWOT Analysis

Table 88. Sateri Chemical Fibre Recent Developments

Table 89. Xinjiang Zhongtai Corporation Information

Table 90. Xinjiang Zhongtai Description and Major Businesses

Table 91. Xinjiang Zhongtai Product Models, Descriptions and Specifications

Table 92. Xinjiang Zhongtai Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Xinjiang Zhongtai Sales Value Proportion by Product in 2024

Table 94. Xinjiang Zhongtai Sales Value Proportion by Application in 2024

Table 95. Xinjiang Zhongtai Sales Value Proportion by Geographic Area in 2024

Table 96. Xinjiang Zhongtai Medical Strong Viscose Fiber SWOT Analysis

Table 97. Xinjiang Zhongtai Recent Developments

Table 98. Aoyang Technology Corporation Information

Table 99. Aoyang Technology Description and Major Businesses

Table 100. Aoyang Technology Product Models, Descriptions and Specifications

Table 101. Aoyang Technology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 102. Aoyang Technology Recent Developments

Table 103. Sateri Corporation Information

Table 104. Sateri Description and Major Businesses

Table 105. Sateri Product Models, Descriptions and Specifications

Table 106. Sateri Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 107. Sateri Recent Developments

Table 108. Shandong Bohi Corporation Information

Table 109. Shandong Bohi Description and Major Businesses

Table 110. Shandong Bohi Product Models, Descriptions and Specifications

Table 111. Shandong Bohi Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 112. Shandong Bohi Recent Developments

Table 113. Yibin Grace Group Company Corporation Information

Table 114. Yibin Grace Group Company Description and Major Businesses

Table 115. Yibin Grace Group Company Product Models, Descriptions and Specifications

Table 116. Yibin Grace Group Company Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 117. Yibin Grace Group Company Recent Developments

Table 118. Celliant Corporation Information

Table 119. Celliant Description and Major Businesses

Table 120. Celliant Product Models, Descriptions and Specifications

Table 121. Celliant Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 122. Celliant Recent Developments

Table 123. Key Raw Materials Distribution

Table 124. Raw Materials Key Suppliers

Table 125. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 126. Milestones in Production Technology Evolution

Table 127. Distributors List

Table 128. Market Trends and Market Evolution

Table 129. Market Drivers and Opportunities

Table 130. Market Challenges, Risks, and Restraints

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Medical Strong Viscose Fiber Product Picture

Figure 2. Global Medical Strong Viscose Fiber Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Viscose Filament Yarn Product Picture

Figure 4. Viscose Staple Fiber Product Picture

Figure 5. Global Medical Strong Viscose Fiber Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Medical Dressings

Figure 7. Medical Bandages

Figure 8. Other

Figure 9. Medical Strong Viscose Fiber Report Years Considered

Figure 10. Global Medical Strong Viscose Fiber Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 12. Global Medical Strong Viscose Fiber Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Medical Strong Viscose Fiber Revenue Market Share by Region (2020-2031)

Figure 14. Global Medical Strong Viscose Fiber Sales (2020-2031) & (Tons)

Figure 15. Global Medical Strong Viscose Fiber Sales (CAGR) by Region (2020-2031) (Tons)

Figure 16. Global Medical Strong Viscose Fiber Sales Market Share by Region (2020-2031)

Figure 17. Global Medical Strong Viscose Fiber Capacity, Production and Utilization (2020-2031) & (Tons)

Figure 18. Global Medical Strong Viscose Fiber Production Trend by Region (2020-2031) (Tons)

Figure 19. Global Medical Strong Viscose Fiber Production Market Share by Region (2020-2031)

Figure 20. Production Capacity Enablers & Constraints

Figure 21. Medical Strong Viscose Fiber Production Growth Rate in North America (2020-2031) & (Tons)

Figure 22. Medical Strong Viscose Fiber Production Growth Rate in Europe (2020-2031) & (Tons)

Figure 23. Medical Strong Viscose Fiber Production Growth Rate in China (2020-2031) & (Tons)

Figure 24. Medical Strong Viscose Fiber Production Growth Rate in Japan (2020-2031) & (Tons)

Figure 25. Top 5 and Top 10 Manufacturers Medical Strong Viscose Fiber Sales Volume Market Share in 2024

Figure 26. Global Medical Strong Viscose Fiber Revenue Market Share Ranking (2024)

Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 28. Viscose Filament Yarn Revenue Market Share by Manufacturer in 2024

Figure 29. Viscose Staple Fiber Revenue Market Share by Manufacturer in 2024

Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 32. Global Medical Strong Viscose Fiber Sales Market Share by Type (2020-2031)

Figure 33. Global Medical Strong Viscose Fiber Revenue Market Share by Type (2020-2031)

Figure 34. Global Medical Strong Viscose Fiber Sales Market Share by Application (2020-2031)

Figure 35. Global Medical Strong Viscose Fiber Revenue Market Share by Application (2020-2031)

Figure 36. North America Medical Strong Viscose Fiber Sales YoY (2020-2031) & (Tons)

Figure 37. North America Medical Strong Viscose Fiber Revenue YoY (2020-2031) & (US$ Million)

Figure 38. North America Top 5 Manufacturers Medical Strong Viscose Fiber Sales Revenue (US$ Million) in 2024

Figure 39. North America Medical Strong Viscose Fiber Sales Volume (Tons) by Type (2020- 2031)

Figure 40. North America Medical Strong Viscose Fiber Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 41. North America Medical Strong Viscose Fiber Sales Volume (Tons) by Application (2020-2031)

Figure 42. North America Medical Strong Viscose Fiber Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. US Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 44. Canada Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 45. Mexico Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 46. Europe Medical Strong Viscose Fiber Sales YoY (2020-2031) & (Tons)

Figure 47. Europe Medical Strong Viscose Fiber Revenue YoY (2020-2031) & (US$ Million)

Figure 48. Europe Top 5 Manufacturers Medical Strong Viscose Fiber Sales Revenue (US$ Million) in 2024

Figure 49. Europe Medical Strong Viscose Fiber Sales Volume (Tons) by Type (2020-2031)

Figure 50. Europe Medical Strong Viscose Fiber Sales Revenue (US$ Million) by Type (2020-2031)

Figure 51. Europe Medical Strong Viscose Fiber Sales Volume (Tons) by Application (2020-2031)

Figure 52. Europe Medical Strong Viscose Fiber Sales Revenue (US$ Million) by Application (2020-2031)

Figure 53. Germany Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 54. France Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 55. U.K. Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 56. Italy Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 57. Russia Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 58. Asia-Pacific Medical Strong Viscose Fiber Sales YoY (2020-2031) & (Tons)

Figure 59. Asia-Pacific Medical Strong Viscose Fiber Revenue YoY (2020-2031) & (US$ Million)

Figure 60. Asia-Pacific Top 8 Manufacturers Medical Strong Viscose Fiber Sales Revenue (US$ Million) in 2024

Figure 61. Asia-Pacific Medical Strong Viscose Fiber Sales Volume (Tons) by Type (2020- 2031)

Figure 62. Asia-Pacific Medical Strong Viscose Fiber Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 63. Asia-Pacific Medical Strong Viscose Fiber Sales Volume (Tons) by Application (2020-2031)

Figure 64. Asia-Pacific Medical Strong Viscose Fiber Sales Revenue (US$ Million) by Application (2020-2031)

Figure 65. Indonesia Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 66. Japan Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 67. South Korea Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 68. China Taiwan Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 69. India Medical Strong Viscose Fiber Revenue (2020-2031) & (US$ Million)

Figure 70. Central and South America Medical Strong Viscose Fiber Sales YoY (2020-2031) & (Tons)

Figure 71. Central and South America Medical Strong Viscose Fiber Revenue YoY (2020-2031) & (US$ Million)

Figure 72. Central and South America Top 5 Manufacturers Medical Strong Viscose Fiber Sales Revenue (US$ Million) in 2024

Figure 73. Central and South America Medical Strong Viscose Fiber Sales Volume (Tons) by Type (2021-2031)

Figure 74. Central and South America Medical Strong Viscose Fiber Sales Revenue (US$ Million) by Type (2020-2031)

Figure 75. Central and South America Medical Strong Viscose Fiber Sales Volume (Tons) by Application (2020-2031)

Figure 76. Central and South America Medical Strong Viscose Fiber Sales Revenue (US$ Million) by Application (2020-2031)

Figure 77. Brazil Medical Strong Viscose Fiber Revenue (2020-2025) & (US$ Million)

Figure 78. Argentina Medical Strong Viscose Fiber Revenue (2020-2025) & (US$ Million)

Figure 79. Middle East, and Africa Medical Strong Viscose Fiber Sales YoY (2020-2031) & (Tons)

Figure 80. Middle East and Africa Medical Strong Viscose Fiber Revenue YoY (2020-2031) & (US$ Million)

Figure 81. Middle East and Africa Top 5 Manufacturers Medical Strong Viscose Fiber Sales Revenue (US$ Million) in 2024

Figure 82. Middle East and Africa Medical Strong Viscose Fiber Sales Volume (Tons) by Type (2021-2031)

Figure 83. South America Medical Strong Viscose Fiber Sales Revenue (US$ Million) by Type (2020-2031)

Figure 84. Middle East and Africa Medical Strong Viscose Fiber Sales Volume (Tons) by Application (2020-2031)

Figure 85. Middle East and Africa Medical Strong Viscose Fiber Sales Revenue (US$ Million) by Application (2020-2031)

Figure 86. GCC Countries Medical Strong Viscose Fiber Revenue (2020-2025) & (US$ Million)

Figure 87. Turkey Medical Strong Viscose Fiber Revenue (2020-2025) & (US$ Million)

Figure 88. Egypt Medical Strong Viscose Fiber Revenue (2020-2025) & (US$ Million)

Figure 89. South Africa Medical Strong Viscose Fiber Revenue (2020-2025) & (US$ Million)

Figure 90. Medical Strong Viscose Fiber Industry Chain Mapping

Figure 91. Regional Medical Strong Viscose Fiber Manufacturing Base Distribution (%)

Figure 92. Medical Strong Viscose Fiber Production Process

Figure 93. Regional Medical Strong Viscose Fiber Production Cost Structure

Figure 94. Channels of Distribution (Direct Vs Distribution)

Figure 95. Bottom-up and Top-down Approaches for This Report

Figure 96. Data Triangulation

Figure 97. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-36J17744

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Flash Spinning Non-woven Fabrics for Medical Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-34K17467

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Medical Strong Viscose Fiber Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-32Z17692

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Faux Fur Coats and Clothing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28A19709

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Medical Strong Viscose Fiber Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-32Z17692

Global Medical Strong Viscose Fiber Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Medical Strong Viscose Fiber Market Size

Medical Strong Viscose Fiber Market

Report Includes:

Scope of Medical Strong Viscose Fiber Market Report

Chapter Outline

FAQ for this report

How fast is Medical Strong Viscose Fiber Market growing?

What is the Medical Strong Viscose Fiber Market size in 2031?

Who are the main players in the Medical Strong Viscose Fiber Market report?

What are the Application segmentation covered in the Medical Strong Viscose Fiber Market report?

What are the Type segmentation covered in the Medical Strong Viscose Fiber Market report?

FEATURED COMPANIES

RELATED REPORTS